{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:48:40Z","timestamp":1777657720036,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Public Welfare Special Funds for Agriculture Scientific Research","award":["201203039"],"award-info":[{"award-number":["201203039"]}]},{"name":"Public Welfare Special Funds for Agriculture Scientific Research","award":["2011AA10A208"],"award-info":[{"award-number":["2011AA10A208"]}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["31101837"],"award-info":[{"award-number":["31101837"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Laboratory of Veterinary Biotechnology","award":["SKLVBP201203"],"award-info":[{"award-number":["SKLVBP201203"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.056","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T19:29:53Z","timestamp":1433532593000},"page":"3752-3757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein"],"prefix":"10.1016","volume":"33","author":[{"given":"Long-Jun","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Wu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.056_bib0170","first-page":"44","article-title":"Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome","volume":"39","author":"Ellis","year":"1998","journal-title":"Can Vet J"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0175","first-page":"201","article-title":"Recognizing and diagnosing postweaning multisystemic wasting syndrome (PMWS)","volume":"5","author":"Harding","year":"1997","journal-title":"Swine Health Prod"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0180","first-page":"153","article-title":"Characterization of papovavirus- and picornavirus-like particles in permanent pig kidney cell lines","volume":"226","author":"Tischer","year":"1974","journal-title":"Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene Erste Abteilung Originale Reihe A: Medizinische Mikrobiologie und Parasitologie"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/295064a0","article-title":"A very small porcine virus with circular single-stranded DNA","volume":"295","author":"Tischer","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0190","series-title":"Virus taxonomy: eighth report of the international committee on taxonomy of viruses","author":"Thiel","year":"2005"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1099\/0022-1317-79-2-381","article-title":"Identification of a protein essential for replication of porcine circovirus","volume":"79","author":"Mankertz","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0200","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1099\/0022-1317-81-9-2281","article-title":"Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein","volume":"81","author":"Nawagitgul","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0205","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00705-006-0909-6","article-title":"Detection of two porcine circovirus type 2 genotypic groups in United States swine herds","volume":"152","author":"Cheung","year":"2007","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0210","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/vr.162.26.867","article-title":"PCV-2 genotype definition and nomenclature","volume":"162","author":"Segal\u00e9s","year":"2008","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.meegid.2015.01.006","article-title":"Genetic characterisation and phylogenetic analysis of PCV2 isolates from India: indications for emergence of natural inter-genotypic recombinants","volume":"13","author":"Anoopraj","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0220","doi-asserted-by":"crossref","first-page":"00987","DOI":"10.1128\/genomeA.00987-14","article-title":"Complete genome sequence of porcine circovirus type 2 strain HB-MC1","volume":"2","author":"Yuan","year":"2014","journal-title":"Genome Announc"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0225","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12917-014-0286-4","article-title":"Variation in time and magnitude of immune response and viremia in experimental challenges with porcine circovirus 2b","volume":"10","author":"Engle","year":"2014","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0230","first-page":"12276","article-title":"Emergence of porcine circovirus 2 associated reproductive failure in Southern India","volume":"15","author":"Karuppannan","year":"2014","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1743-422X-8-88","article-title":"Genetic characterization of porcine circovirus type 2 in piglets from PMWS-affected and-negative farms in Thailand","volume":"8","author":"Jantafong","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11262-009-0438-y","article-title":"Genetic analysis of porcine circovirus type 2 (PCV2) strains isolated between 2001 and 2009: genotype PCV2b predominate in postweaning multisystemic wasting syndrome occurrences in eastern China","volume":"40","author":"Li","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1743-422X-7-273","article-title":"Porcine circovirus type 2 (PCV2): genetic variation and newly emerging genotypes in China","volume":"7","author":"Guo","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0250","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.rvsc.2007.05.017","article-title":"Genetic characterization of porcine circovirus type 2 in Republic of Korea","volume":"84","author":"Choi","year":"2008","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00705-014-2300-3","article-title":"Phylogenetic analysis of 32 porcine circovirus type 2 isolates from Shandong","volume":"160","author":"Shi","year":"2015","journal-title":"China Arch Virol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2012.01.008","article-title":"Identification of an emerging recombinant cluster in porcine circovirus type 2","volume":"165","author":"Cai","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2011.08.004","article-title":"Porcine circovirus genotype 2a (PCV2a) and genotype 2b (PCV2b) recombinant mutants showed significantly enhanced viral replication and altered antigenicity in vitro","volume":"419","author":"Guo","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vaccine.2013.11.010","article-title":"A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 US variant mPCV2b strain","volume":"32","author":"Opriessnig","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0275","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1016\/j.vaccine.2014.06.004","article-title":"Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2","volume":"32","author":"Opriessnig","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0280","doi-asserted-by":"crossref","first-page":"e41463","DOI":"10.1371\/journal.pone.0041463","article-title":"A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a\/b strain","volume":"7","author":"Guo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1292\/jvms.66.237","article-title":"Development of an ELISA based on the baculovirus-expressed capsid protein of porcine circovirus type 2 as antigen","volume":"66","author":"Liu","year":"2004","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0290","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2012.11.062","article-title":"Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-\u03b3 in mice","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0295","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virusres.2011.05.015","article-title":"Construction and biological characterisation of recombinant porcine circovirus type 2 expressing the V5 epitope tag","volume":"161","author":"Huang","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/01652176.2002.9695132","article-title":"Postweaning mulstisystemic wasting syndrome (PMWS) in pigs. A review","volume":"24","author":"Segal\u00e9s","year":"2002","journal-title":"Vet Q"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1079\/AHR2005106","article-title":"Porcine circovirus diseases","volume":"6","author":"Segal\u00e9s","year":"2005","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1292\/jvms.09-0314","article-title":"Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms","volume":"72","author":"Takahagi","year":"2010","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0315","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.vaccine.2012.11.030","article-title":"A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a\/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection","volume":"31","author":"Opriessnig","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0320","doi-asserted-by":"crossref","first-page":"13440","DOI":"10.1128\/JVI.78.24.13440-13446.2004","article-title":"Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo","volume":"78","author":"Fenaux","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0325","doi-asserted-by":"crossref","first-page":"11232","DOI":"10.1128\/JVI.77.20.11232-11243.2003","article-title":"Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs","volume":"77","author":"Fenaux","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.056_bib0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2009.02.009","article-title":"Porcine circoviruses\u2014small but powerful","volume":"143","author":"Finsterbusch","year":"2009","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:45:09Z","timestamp":1565419509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15007197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":33,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15007197"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}